Cardiovascular and metabolic risk

Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study
Ingrid Hougen, Reid H Whitlock, Paul Komenda, Claudio Rigatto, Kristin K Clemens, Navdeep Tangri

BMJ Open Diabetes Research and Care Dec 2021, 9 (2) e002352; DOI: 10.1136/bmjdrc-2021-002352
Application of machine learning techniques to understand ethnic differences and risk factors for incident chronic kidney disease in Asians
Cynthia Ciwei Lim, Feng He, Jialiang Li, Yih Chung Tham, Chieh Suai Tan, Ching-Yu Cheng, Tien-Yin Wong, Charumathi Sabanayagam

BMJ Open Diabetes Research and Care Dec 2021, 9 (2) e002364; DOI: 10.1136/bmjdrc-2021-002364
Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
Lukas Sprenger, Arthur Mader, Barbara Larcher, Maximilian Mächler, Alexander Vonbank, Daniela Zanolin-Purin, Andreas Leiherer, Axel Muendlein, Heinz Drexel, Christoph H Saely

BMJ Open Diabetes Research and Care Nov 2021, 9 (2) e002407; DOI: 10.1136/bmjdrc-2021-002407
Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control
Christophe Kosinski, Jean-Benoît Rossel, Justine Gross, Céline Helbling, Dan Yedu Quansah, Tinh-Hai Collet, Jardena J Puder

BMJ Open Diabetes Research and Care Nov 2021, 9 (2) e002382; DOI: 10.1136/bmjdrc-2021-002382
Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial
Samuel Dagogo-Jack, Richard E Pratley, David Z I Cherney, Darren K McGuire, Francesco Cosentino, Weichung J Shih, Jie Liu, Robert Frederich, James P Mancuso, Annaswamy Raji, Ira Gantz

BMJ Open Diabetes Research and Care Oct 2021, 9 (1) e002484; DOI: 10.1136/bmjdrc-2021-002484
Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies
Shajith Anoop S, Riddhi Dasgupta, Grace Rebekah, Arun Jose, Mercy Prem Inbakumari, Geethanjali Finney, Nihal Thomas

BMJ Open Diabetes Research and Care Sep 2021, 9 (1) e002414; DOI: 10.1136/bmjdrc-2021-002414
Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study
M C Sage Ishimwe, Annemarie Wentzel, Elyssa M Shoup, Nana H Osei-Tutu, Thomas Hormenu, Arielle C Patterson, Hadi Bagheri, Christopher W DuBose, Lilian S Mabundo, Joon Ha, Arthur Sherman, Anne E Sumner

BMJ Open Diabetes Research and Care Sep 2021, 9 (1) e002447; DOI: 10.1136/bmjdrc-2021-002447
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
Emilie H Zobel, Asger Wretlind, Rasmus S Ripa, Viktor Rotbain Curovic, Bernt J von Scholten, Tommi Suvitaival, Tine W Hansen, Andreas Kjær, Cristina Legido-Quigley, Peter Rossing

BMJ Open Diabetes Research and Care Sep 2021, 9 (1) e002395; DOI: 10.1136/bmjdrc-2021-002395
Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study
Fariba Ahmadizar, Kan Wang, Elif Aribas, Lana Fani, Alis Heshmatollah, M Kamran Ikram, Maryam Kavousi

BMJ Open Diabetes Research and Care Aug 2021, 9 (1) e002406; DOI: 10.1136/bmjdrc-2021-002406
Developing a health economic model for Asians with type 2 diabetes based on the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial
Shiro Tanaka, Jakob Langer, Tim Morton, Nicki Hoskins, Lars Wilkinson, Sachiko Tanaka-Mizuno, Ryo Kawasaki, Tatsumi Moriya, Chika Horikawa, Rei Aida, Atsushi Araki, Kazuya Fujihara, Hirohito Sone

BMJ Open Diabetes Research and Care Aug 2021, 9 (1) e002177; DOI: 10.1136/bmjdrc-2021-002177

Main menu

Cardiovascular and metabolic risk

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cardiovascular and metabolic risk

Pages